Clinical Trial Update: Beta-glucan-chitin-chitosan Polymer Supplement in Overweight/Obese Subjects: Cardiovascular Risk Biomarkers (QUITOVASC) [NA]

View source ↗

Summary

A completed clinical trial evaluating a beta-glucan-chitin-chitosan polymer supplement on cardiovascular risk biomarkers in overweight/obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Drugs mentioned

• Beta-glucan-chitin-chitosan polymer supplement (beta-glucan-chitin-chitosan polymer supplement)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Dietary Exposure | NA | Status: COMPLETED